GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pluri Inc (NAS:PLUR) » Definitions » Cyclically Adjusted PB Ratio

Pluri (PLUR) Cyclically Adjusted PB Ratio : 0.25 (As of Jun. 27, 2025)


View and export this data going back to 1991. Start your Free Trial

What is Pluri Cyclically Adjusted PB Ratio?

As of today (2025-06-27), Pluri's current share price is $5.09. Pluri's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was $20.69. Pluri's Cyclically Adjusted PB Ratio for today is 0.25.

The historical rank and industry rank for Pluri's Cyclically Adjusted PB Ratio or its related term are showing as below:

PLUR' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.12   Med: 0.8   Max: 2.97
Current: 0.24

During the past years, Pluri's highest Cyclically Adjusted PB Ratio was 2.97. The lowest was 0.12. And the median was 0.80.

PLUR's Cyclically Adjusted PB Ratio is ranked better than
80.38% of 683 companies
in the Biotechnology industry
Industry Median: 1.49 vs PLUR: 0.24

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pluri's adjusted book value per share data for the three months ended in Mar. 2025 was $-0.575. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $20.69 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pluri Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Pluri's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pluri Cyclically Adjusted PB Ratio Chart

Pluri Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.40 0.65 0.22 0.18 0.22

Pluri Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.22 0.25 0.19 0.21

Competitive Comparison of Pluri's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Pluri's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pluri's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pluri's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pluri's Cyclically Adjusted PB Ratio falls into.


;
;

Pluri Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Pluri's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=5.09/20.69
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pluri's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Pluri's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.575/134.9266*134.9266
=-0.575

Current CPI (Mar. 2025) = 134.9266.

Pluri Quarterly Data

Book Value per Share CPI Adj_Book
201506 59.028 100.684 79.103
201509 52.877 100.392 71.067
201512 49.497 99.792 66.924
201603 43.063 100.470 57.831
201606 38.042 101.688 50.477
201609 32.577 101.861 43.152
201612 24.719 101.863 32.743
201703 29.636 102.862 38.874
201706 24.960 103.349 32.586
201709 19.857 104.136 25.728
201712 27.038 104.011 35.075
201803 23.974 105.290 30.722
201806 20.075 106.317 25.477
201809 15.024 106.507 19.033
201812 10.407 105.998 13.247
201903 5.786 107.251 7.279
201906 11.576 108.070 14.453
201909 8.979 108.329 11.184
201912 7.515 108.420 9.352
202003 6.071 108.902 7.522
202006 17.603 108.767 21.837
202009 15.287 109.815 18.783
202012 12.739 109.897 15.640
202103 17.171 111.754 20.731
202106 14.306 114.631 16.839
202109 12.190 115.734 14.211
202112 9.891 117.630 11.345
202203 9.422 121.301 10.480
202206 7.393 125.017 7.979
202209 5.931 125.227 6.390
202212 4.846 125.222 5.222
202303 3.713 127.348 3.934
202306 2.590 128.729 2.715
202309 1.718 129.860 1.785
202312 0.844 129.419 0.880
202403 -0.068 131.776 -0.070
202406 0.018 132.554 0.018
202409 -0.959 133.029 -0.973
202412 -1.443 133.157 -1.462
202503 -0.575 134.927 -0.575

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pluri  (NAS:PLUR) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Pluri Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Pluri's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pluri Business Description

Industry
Traded in Other Exchanges
Address
MATAM Advanced Technology Park, Building No.5, Haifa, ISR, 3508409
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.
Executives
Lorne Kenneth Abony director MATAM PARK, BUILDING #5, HAIFA L3 3508409
Zami Aberman officer: Chief Executive Officer 63 RABUTZKY STREET, RAANANA L3 43220
Varda Shalev director MATAM PARK, BUILDING #5, HAIFA L3 3508409
Pinhas Doron Birger director MATAM PARK, BUILDING #5, HAIFA L3 3508409
Clover Wolf Capital - Limited Partnership 10 percent owner BOODENHIMER 24, TEL AVIV L3 6200838
Rami Avraham Levi director MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA L3 3508409
Maital Shemesh-rasmussen director MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA L3 3508409
Doron Shorrer director 33 KOREH PLADORR ST, JERUSALEM L3 93393
Isaac Braun director 9 ZEHARIA STREET, BENE BARAK L3 51540
Yaky Yanay officer: Chief Financial Officer ARGAMAN 14, SHIMSHIT L3 17906
Moria Kwiat director HAKFAR 11, KIRYAT ONO L3 55525
Israel Ben-yoram director 24 BARKAN STREET, RISHON LEZION L3 00000
Chen Franco-yehuda officer: Chief Financial Officer MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA L3 31905
Mark Germain director WELLSFORD REAL PROPERTIES INC, 535 MADISON AVENUE, NEW YORK NY 10022
Erez Egozi officer: Chief Financial Officer MATAM PARK, BUILDING 05, HAIFA L3 31905

Pluri Headlines

From GuruFocus

Pluri to Present and Participate in Upcoming Conferences

By Value_Insider Value_Insider 10-31-2022

Pluri CEO Issues Shareholder Update

By PurpleRose PurpleRose 07-25-2022